An Introduction to the Molecular Genetics of Neurological Disease

Rosenberg, Roger N.

doi:10.1001/archneur.1993.00540110005001

Cited by 8 publications

(1 citation statement)

References 60 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The recent developments of stem cell gene therapy and the CRISPR CAS9 method make it highly probable that gene therapy can be effectively realized to delay, prevent, or reverse inherited neurological disease. [5][6][7] Pharmaconeuromic-specific therapies are being planned and will be developed by virtue of the genomic revolution. JAMA Neurology has been intimately involved in documenting and advancing neuromics over the past 20 years.…”

Section: Jama Neurology At the Forefront 1997-2016mentioning

confidence: 99%

JAMA Neurology at the Forefront, 1997-2016

Rosenberg

2016

JAMA Neurol

View full text Add to dashboard Cite

ecosystems that simply do not apply to print publishing. Whether readers, authors, institutions, or funders support the costs of publishing, publishing to a contemporary online standard-making medical science discoverable, mobile, consumable, and social-is a complex, full-time, and ongoing program that should be a part of conversations about the standards and costs of how to make science more accessible and open.We have thought through every pixel of every page of the new platform. We believe we are delivering a better experi-ence but surely have gotten some things wrong or overlooked others. Websites, like cars, depreciate rapidly the instant proud new owners take possession of them, so we are committed to a plan-do-study-act quality improvement process: having planned and launched the site we will now closely watch what is working and what is not, listen to and solicit comments from our many users, and revise the site continually and appropriately. We encourage users and readers to visit our FAQ website and give us feedback at

show abstract

Section: Jama Neurology At the Forefront 1997-2016mentioning

confidence: 99%